Target intelligence / Profile preview

Renal tissue regeneration and repair pathways

Molecular classification
Other
01

Overview

Renal tissue regeneration and repair pathways represent the collective molecular and cellular mechanisms that the kidney employs to restore its structural integrity and physiological function after injury (NIH, 2017). These pathways are primarily activated in response to acute kidney injury (AKI) and involve the dedifferentiation, migration, and proliferation of surviving tubular epithelial cells, often driven by developmental signaling cascades such as Wnt/beta-catenin, Notch, and Hedgehog (ScienceDaily, 2010; NIH, 2024). Key growth factors, including Hepatocyte Growth Factor (HGF) and Bone Morphogenetic Protein 7 (BMP-7), play critical roles in promoting cell survival and functional recovery (ResearchGate, 2015). While the kidney has a significant capacity for endogenous repair, severe or repetitive injury can lead to maladaptive repair processes characterized by chronic inflammation and the development of renal fibrosis (TechnologyNetworks, 2025). Therapeutic interventions in this area focus on augmenting these natural regenerative pathways or inhibiting the transition to fibrosis to prevent the progression to chronic kidney disease (CKD) (ShebaOnline, 2024). Experimental therapies such as HGF mimetics (e.g., ANG-3777) and BMP-7 mimetics (e.g., THR-184) have been investigated to stimulate these pathways and improve clinical outcomes in patients with renal impairment (NIH, 2021).

Other names
Kidney repair pathwaysRenal regenerative pathwaysEndogenous renal repair mechanismsTubular regeneration pathways
02

Mechanism of action

Activation of endogenous repair mechanisms, such as the HGF/c-Met, Wnt/beta-catenin, and BMP-7 pathways, to promote tubular epithelial cell survival and proliferation while inhibiting fibrotic transformation.

03

Biological functions

Cell proliferationCell differentiationApoptosisSignal transductionTissue remodelingWound healing
04

Disease associations

Acute Kidney InjuryChronic Kidney DiseaseRenal FibrosisEnd-Stage Renal Disease
05

Safety considerations

Potential for oncogenic transformation due to sustained growth factor signalingRisk of maladaptive repair leading to fibrosisImmunogenicity of cell-based therapies
06

Interacting drugs

ANG-3777

5 more in the full profile.

07

Biomarkers

Kidney Injury Molecule-1 (KIM-1)Neutrophil Gelatinase-Associated Lipocalin (NGAL)SOX9Serum creatinineCystatin C

Beyond the preview

Go deeper on Renal tissue regeneration and repair pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal tissue regeneration and repair pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call